{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:42:44Z","timestamp":1761061364347,"version":"3.37.3"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T00:00:00Z","timestamp":1616457600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T00:00:00Z","timestamp":1616457600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"CIBER of Epidemiology and Public Health","award":["Subprogram \u201cCancer surveillance\u201d"],"award-info":[{"award-number":["Subprogram \u201cCancer surveillance\u201d"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Popul Health Metrics"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Population-based cancer registries are required to calculate cancer incidence in a geographical area, and several methods have been developed to obtain estimations of cancer incidence in areas not covered by a cancer registry. However, an extended analysis of those methods in order to confirm their validity is still needed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We assessed the validity of one of the most frequently used methods to estimate cancer incidence, on the basis of cancer mortality data and the incidence-to-mortality ratio (IMR), the IMR method. Using the previous 15-year cancer mortality time series, we derived the expected yearly number of cancer cases in the period 2004\u20132013 for six cancer sites for each sex. Generalized linear mixed models, including a polynomial function for the year of death and smoothing splines for age, were adjusted. Models were fitted under a Bayesian framework based on Markov chain Monte Carlo methods. The IMR method was applied to five scenarios reflecting different assumptions regarding the behavior of the IMR. We compared incident cases estimated with the IMR method to observed cases diagnosed in 2004\u20132013 in Granada. A goodness-of-fit (GOF) indicator was formulated to determine the best estimation scenario.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 39,848 cancer incidence cases and 43,884 deaths due to cancer were included. The relative differences between the observed and predicted numbers of cancer cases were less than 10% for most cancer sites. The constant assumption for the IMR trend provided the best GOF for colon, rectal, lung, bladder, and stomach cancers in men and colon, rectum, breast, and corpus uteri in women. The linear assumption was better for lung and ovarian cancers in women and prostate cancer in men. In the best scenario, the mean absolute percentage error was 6% in men and 4% in women for overall cancer. Female breast cancer and prostate cancer obtained the worst GOF results in all scenarios.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>A comparison with a historical time series of real data in a population-based cancer registry indicated that the IMR method is a valid tool for the estimation of cancer incidence. The goodness-of-fit indicator proposed can help select the best assumption for the IMR based on a statistical argument.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12963-021-00248-1","type":"journal-article","created":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T19:07:04Z","timestamp":1616526424000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Cancer incidence estimation from mortality data: a validation study within a population-based cancer registry"],"prefix":"10.1186","volume":"19","author":[{"given":"Daniel","family":"Redondo-S\u00e1nchez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9972-9779","authenticated-orcid":false,"given":"Miguel","family":"Rodr\u00edguez-Barranco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Ameijide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco Javier","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Fern\u00e1ndez-Navarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Juan","family":"Jim\u00e9nez-Mole\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda-Jos\u00e9","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,23]]},"reference":[{"key":"248_CR1","first-page":"60","volume-title":"Cancer epidemiology: principles and methods, Chapter 4: Measures of occurrence of disease and other health related events","author":"I dos Santos Silva","year":"1999","unstructured":"dos Santos Silva I. Cancer epidemiology: principles and methods, Chapter 4: Measures of occurrence of disease and other health related events. Lyon: International Agency for Research on Cancer; 1999. p. 60\u20133. Available from: http:\/\/publications.iarc.fr\/Non-Series-Publications\/Other-Non-Series-Publications\/Cancer-Epidemiology-Principles-And-Methods-1999. [cited 2019 Jan 3]"},{"key":"248_CR2","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.ejca.2008.11.032","volume":"45","author":"F Bray","year":"2009","unstructured":"Bray F, Parkin DM. Evaluation of data quality in the cancer registry: principles and methods. Part I: comparability, validity and timeliness. Eur J Cancer. 2009;45:747\u201355 Available from: http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804908009209. [cited 2018 May 28].","journal-title":"Eur J Cancer"},{"key":"248_CR3","doi-asserted-by":"crossref","unstructured":"Parkin DM, Bray F. Evaluation of data quality in the cancer registry: principles and methods Part II. Completeness. Eur J Cancer 2009;45:756\u2013764. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19128954. [cited 2018 May 28]","DOI":"10.1016\/j.ejca.2008.11.033"},{"key":"248_CR4","unstructured":"Forman D, Bray F, Brewster DH, Gombe Mbalawa C, Kohler B, Pi\u00f1eros M, Znaor A, Zanetti R and Ferlay J E. Cancer incidence in five continents, Vol. XI. Lyon Int. Agency Res. Cancer. 2017. Available from: http:\/\/ci5.iarc.fr. [cited 2018 Jun 13]"},{"key":"248_CR5","volume-title":"ECIS - European Cancer Information System","author":"Joint Research Center-European Commission","year":"2018","unstructured":"Joint Research Center-European Commission. ECIS - European Cancer Information System. 2018. Available from: https:\/\/ecis.jrc.ec.europa.eu\/. [cited 2018 Jun 13]"},{"key":"248_CR6","volume-title":"Cancer today (powered by GLOBOCAN 2018). IARC CancerBase No. 15","author":"J Ferlay","year":"2018","unstructured":"Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Pi\u00f1eros M, Znaor A, Soerjomataram I BF. Cancer today (powered by GLOBOCAN 2018). IARC CancerBase No. 15. 2018. Available from: http:\/\/publications.iarc.fr\/577. [cited 2018 Dec 23]"},{"key":"248_CR7","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s12094-016-1607-9","volume":"19","author":"J Galceran","year":"2017","unstructured":"Galceran J, Ameijide A, Carulla M, Mateos A, Quir\u00f3s JR, Rojas D, et al. Cancer incidence in Spain, 2015. Clin Transl Oncol. 2017;19:799\u2013825 Available from: http:\/\/link.springer.com\/10.1007\/s12094-016-1607-9. [cited 2017 Jan 19].","journal-title":"Clin Transl Oncol"},{"key":"248_CR8","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","volume":"49","author":"J Ferlay","year":"2013","unstructured":"Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JWW, Comber H, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49:1374\u2013403 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23485231. [cited 2016 Nov 17].","journal-title":"Eur J Cancer"},{"key":"248_CR9","doi-asserted-by":"publisher","unstructured":"Antoni S, Soerjomataram I, M\u00f8ller B, Bray F, Ferlay J. An assessment of GLOBOCAN methods for deriving national estimates of cancer incidence. Bull World Health Organ. 2016;94:174\u201384. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4773935\/. https:\/\/doi.org\/10.2471\/BLT.15.164384.","DOI":"10.2471\/BLT.15.164384"},{"key":"248_CR10","unstructured":"Granada Cancer Registry. Available from: https:\/\/www.registrocancergranada.es\/. [cited 2019 May 11]."},{"key":"248_CR11","doi-asserted-by":"publisher","first-page":"165","DOI":"10.4321\/S1137-66272004000300001","volume":"27","author":"G L\u00f3pez-Abente","year":"2004","unstructured":"L\u00f3pez-Abente G, Poll\u00e1n M, Aragon\u00e9s N, P\u00e9rez G\u00f3mez B, Hern\u00e1ndez Barrera V, Lope V, et al. Situaci\u00f3n del c\u00e1ncer en Espa\u00f1a: incidencia. An Sist Sanit Navar. 2004;27:165\u201373 Available from: http:\/\/scielo.isciii.es\/scielo.php?script=sci_arttext&pid=S1137-66272004000300001&lng=en&nrm=iso&tlng=en.","journal-title":"An Sist Sanit Navar"},{"key":"248_CR12","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/S0213-9111(01)71591-9","volume":"15","author":"V Moreno","year":"2001","unstructured":"Moreno V, Gonz\u00e1lez JR, Soler M, Bosch FX, Kogevinas M, Borr\u00e0s JM. Estimaci\u00f3n de la incidencia de c\u00e1ncer en Espa\u00f1a: per\u00edodo 1993\u20131996. Gac Sanit. 2001;15:380\u20138 Available from: http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213911101715919.","journal-title":"Gac Sanit"},{"key":"248_CR13","unstructured":"Spanish National Institute of Statistics. Continuous Register Statistics. Available from: https:\/\/ine.es\/dyngs\/INEbase\/es\/operacion.htm?c=Estadistica_C&cid=1254736176951&menu=resultados&idp=1254735572981. [cited 2018 Jun 13]"},{"key":"248_CR14","unstructured":"Ministry of Health. Government of Spain. Mortality by cause of death. Available from: https:\/\/pestadistico.inteligenciadegestion.mscbs.es\/publicoSNS\/S\/mortalidad-por-causa-de-muerte. [cited 2018 Jun 13]"},{"key":"248_CR15","volume-title":"ICD-10: International Statistical Classification of diseases and related health problems: 10th revision","author":"World Health Organization (WHO)","year":"1990","unstructured":"World Health Organization (WHO). ICD-10: International Statistical Classification of diseases and related health problems: 10th revision. 1990."},{"issue":"4","key":"248_CR16","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.ejca.2009.12.014","volume":"46","author":"J Ferlay","year":"2010","unstructured":"Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer. 2010;46(4):765\u201381. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804909009265. https:\/\/doi.org\/10.1016\/j.ejca.2009.12.014.","journal-title":"Eur J Cancer"},{"key":"248_CR17","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1002\/sim.1481","volume":"22","author":"B M\u00f8ller","year":"2003","unstructured":"M\u00f8ller B, Fekjaer H, Hakulinen T, Sigvaldason H, Storm HH, Talb\u00e4ck M, et al. Prediction of cancer incidence in the Nordic countries: empirical comparison of different approaches. Stat Med. 2003;22:2751\u201366 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12939784.","journal-title":"Stat Med"},{"key":"248_CR18","first-page":"12","volume":"6","author":"A Thomas","year":"2006","unstructured":"Thomas A, O\u2019Hara B, Ligges U, Sturtz S. Making BUGS open. R News. 2006;6:12\u20137 Available from: https:\/\/cran.r-project.org\/doc\/Rnews\/.","journal-title":"R News"},{"issue":"25","key":"248_CR19","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1002\/sim.3680","volume":"28","author":"D Lunn","year":"2009","unstructured":"Lunn D, Spiegelhalter D, Thomas A, Best N. The BUGS project: evolution, critique and future directions. Stat Med. 2009;28(25):3049\u201367. Available from: http:\/\/doi.wiley.com\/10.1002\/sim.3680.","journal-title":"Stat Med"},{"key":"248_CR20","unstructured":"OpenBUGS. Available from: http:\/\/openbugs.net\/w\/FrontPage.\u00a0[cited 2019 May 11]."},{"key":"248_CR21","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1080\/08898489509525406","volume":"5","author":"DA Ahlburg","year":"1995","unstructured":"Ahlburg DA. Simple versus complex models: evaluation, accuracy, and combining. Math Popul Stud. 1995;5:281\u201390 Available from: http:\/\/www.tandfonline.com\/doi\/abs\/10.1080\/08898489509525406. [cited 2019 May 11].","journal-title":"Math Popul Stud"},{"key":"248_CR22","doi-asserted-by":"publisher","first-page":"iii43","DOI":"10.1093\/annonc\/mdq085","volume":"21","author":"N Ascunce","year":"2010","unstructured":"Ascunce N, Salas D, Zubizarreta R, Almazan R, Ibanez J, Ederra M, et al. Cancer screening in Spain. Ann Oncol. 2010;21:iii43\u201351 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20427360. [cited 2018 Dec 7].","journal-title":"Ann Oncol"}],"container-title":["Population Health Metrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12963-021-00248-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12963-021-00248-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12963-021-00248-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T19:10:57Z","timestamp":1616526657000},"score":1,"resource":{"primary":{"URL":"https:\/\/pophealthmetrics.biomedcentral.com\/articles\/10.1186\/s12963-021-00248-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,23]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["248"],"URL":"https:\/\/doi.org\/10.1186\/s12963-021-00248-1","relation":{},"ISSN":["1478-7954"],"issn-type":[{"type":"electronic","value":"1478-7954"}],"subject":[],"published":{"date-parts":[[2021,3,23]]},"assertion":[{"value":"24 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18"}}